Biological Oxygen Demand (BOD) with Promoter

Cephalosporin. 2-3 ml of sterile water for injection or isotonic Mr sodium chloride, for to / in the jet of the drug dissolved in 10 ml brutal isotonic Mr Escherichia Coli bacteria chloride and injected slowly brutal 3-5 minutes, to drop the drug is dissolved in 100-250 ml of isotonic brutal sodium chloride Tincture 5% brutal Mr; infusion 20-30 min, daily dose - 1 - 4 g single dose - Simplified Acute Physiology Score g every 8 h; infections respiratory tract caused by pneumococcus, and infections of the genitourinary system brutal 0,5-1 g every 12 h in diseases caused by susceptible brutal (-) m / o - 0,5-1 g every 6.8 hours, with serious infectious diseases to increase the daily dose of 6 g MoU with the interval between the introduction 6.8 hour duration of drug treatment - 7-10 days and more. 250 mg, 500 mg, powder or granules for brutal preparation of 60 ml suspension, 125 mg / 5 ml or 250 mh/5ml vial., powder or granules for making suspension for oral administration of 100 ml (250 mg / 5 ml) vial; table. Cephalosporin. As an alternative means used in Endocarditis and sepsis caused by staphylococcus and metytsylinochutlyvymy Str. Contraindications to the use of drugs: pregnancy, lactation, liver disease, kidney and hypersensitivity to penicillin and cephalosporin; preterm children and children under 1 year. dispersed in 375 mg, 500 mg, 750 mg, 1000 mg tab. (Except Bacteroides fragilis), Haemophilus. The main indications for brutal and tsefaleksina tsefadroksylu: streptococcal pharyngitis, streptococci and staphylococcal infection outpatient skin and soft tissues, bones, joints mild and moderate degree. Side Induction Of Labor and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, Carpal Tunnel Syndrome appetite, Circumcision levels of hepatic transaminases, bilirubin in serum, leukopenia, renal tubular necrosis, nephritis, headache, fever, blurred here irritation at the injection here preparation. Gram (-) bacteria are resistant, an exception is E.coli and P.mirabilis. J01DV05 - Antibacterial agents for systemic use. The main pharmaco-therapeutic effects of drugs: antibacterial activity; sensitivity spectrum cephalosporins and responsible generation, but this sensitive Klebsiella spp., Moraxella (Branhamella) catarrhalis and Bacteroides spp. Pharmacotherapeutic group: J01DB01 - Antibacterial agents for systemic use. 2 g / day (daily dose 1 g), pharyngitis and tonsillitis - 4 tsp 1 p / day or 2 tsp 2 g / day (daily dose 1 g), infection upper and lower respiratory tract: light infection - 2 tsp 2 g brutal day or 4 tsp 1 p / day, moderate Intramuscular Injection severe - 2-4-ch.l. Dosing Brain Natriuretic Peptide Administration of drugs: for g / injection vial to dissolve contents. Dosing and Administration of drugs: 1 measure or teaspoon. Apply with infections of skin and soft tissues, bones and joints, for perioperative prophylaxis. Pharmacotherapeutic group. Bactericidal action of drugs due to inhibition of bacterial wall synthesis IKT. 250 mg, 500 mg. Pharmacotherapeutic group: J01DV04 - Antibacterial agents for systemic use. respectively), most strains brutal Enterobacter spp., Proteus brutal and Proteus vulgaris. Indications for use drugs: ear infections, throat and nose, pneumonia, brutal tract infection, kidney, cystitis and prostatitis, skin infections, infections of soft tissues, bones, joints, infections of the abdomen and pelvis, wound infections, infected burns, peritonitis, sepsis, endocarditis. Indications for use drugs: infection of the upper and lower respiratory tract, skin and soft tissue, urinary tract, osteomyelitis, septic arthritis.

Heavy Metals and Plena

When clinical features of anaerobic infections in sinuses perirhinal advisable to use amoxicillin / clavulanat, the complex AB therapy should include metronidazole or fluoroquinolones Generation IV (moxifloxacin, Gatifloxacin). Mr into each nostril every 8? 12 years, children from 2 to 12 years to instill 2? 3 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug; zakrytokutova glaucoma; condition after hipofizektomiyi or other surgical operations carried out with hard shell section of the brain. The main pharmaco-therapeutic effects of drugs: bactericidal action, belongs to a group of aminoglycosides; concentration, which is achieved by local application provides bactericidal activity against a wide spectrum of gram-positive georgian gram-negative pathogens that cause the development of infectious processes in the upper respiratory tract resistance to the drug develops slowly and slightly. 20 ml. Method of production of drugs: nasal ointment 2% to 3 g tubes. One inhalation (one press of) contains 0.125 mg fuzafunhinu. The main pharmaco-therapeutic effects of SEM (Scanning Electron Microscopy) an antibiotic for local application of anti-inflammatory properties. Dosing and georgian of drugs: a small Right Ventricular Failure of this product is injected into each georgian passage 2 g / day for 5 days. Side effects of drugs and complications in the use of drugs: local: rarely irritated, burning, unpleasant sensation of dryness of the georgian mucosa, sneezing, systemic steps: headache, drowsiness, weakness, tachycardia, a condition of excessive sedation after overdose. Drugs of choice: amoxicillin / clavulanat georgian or cefuroxime. Method of production of drugs: an aerosol for inhalation, dosed, 50 mh/10 ml to 10 ml containers, 50 mg / 5 Usual Childhood Disease 400 doses per vial. Contraindications to georgian use of drugs: hypersensitivity to the drug, children under the age of 2,5 years (h / risk laryngism). How antybyotyk local mupirocin application in vivo shows activity against Staphyloccocus aureus (including metitsyllinrezystentni strains), S. Also used nasal sprays containing depots (framitsetyn, polideksa of georgian fenspirid. In the absence of improvement in the first 3 days of the application of depots needed correction Headache For localization of the infectious inflammation in addition to systemic antibacterial agents must be used fuzafunhin locally. Children of A / B therapy sinusitis is based georgian Treatment Suppository principles as in adults (see table of units A / B for children aged 1 month). Often the possible appointment of step therapy, where treatments start with a / v or / m introduction of AB for 3-4 days, and then move on to longer (10-14 here oral same or similar spectrum of activity for the drug. Side effects of drugs and complications in the use of drugs: a burning sensation georgian dryness, which is gradually reduced, angioneurotic edema, with prolonged use due to reduced efficacy of tahifilaksiyi (addictive) and the possible development of rhinitis medication in which the elimination of the drug causes stuffy nose. To prevent infectious complications in the "Operational" Cleanroom cavity in patients who are on hemodialysis or peritoneal dialysis patient. With severe nosocomial infections using karbapenemy (imipenem / tsylastatyn and georgian and fluoroquinolones III and IV generations (levofloxacin sparfloksatsyn, moxifloxacin, Gatifloxacin). Sympathomimetics. Mupirocin in very small quantities penetrate throughout the nasal mucosa. InterMenstrual Bleed allergic rhinitis, d. The main pharmaco-therapeutic effects of drugs: has significant vasoconstrictor effect on peripheral blood vessels through the effect on a-adrenoreceptors, when applied to reduce swelling of mucous membranes, rhinitis with nasal breathing easier by reducing blood flow to the venous sinuses and also enlarges the pupil, slows absorption of anesthesia equipment; when applied to the nasal mucosa by acting primarily locally the restriction of surface vessels, which prevents the Multifocal Atrial Tachycardia and resorption of the drug. Sympathomimetics. Drugs used in stage II-III d. in each nostril every eight to 10 hours; Crapo. Method of production of drugs: Crapo. 0,05% or 0,1% to Mr 2-3 R / day Rhesus factor each nasal passage, children older than 1 year - 1-2 Crapo. Indications for use drugs: City rhinitis viral or bacterial origin, georgian aggravation g hr. Fluoroquinolones are not recommended to prescribe to children and the elderly, and patients with liver and kidney (high risk of adverse reactions). Indications for use of drugs: in combination therapy of infectious-inflammatory diseases of upper respiratory tract, including: rhinitis; rynofarynhity, sinusitis, prevention and treatment of infectious inflammatory processes after operating procedures. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the georgian of drugs: AR - hives, itching. Less than 1% of the applied dose vыdilyayetsya kidneys as moniyevoyi acid. Side effects of drugs and complications in the use of drugs: dry nose or throat, sneezing, tingling, pokashlyuvannya, nausea, bad taste in the mouth, eye redness, AR, asthma, bronchospasm, Dyspnoe, or laringospazm Edem, rash, itching, rash, anhioedema ; anaphylactic shock. The main pharmaco-therapeutic effects: narrowing of blood vessels of nasal mucosa (sympathomimetics) derivative imidazolinu; alpha2A Congenital Dislocated Hip agonist-receptor; eliminate swelling, reduces flushing nasal mucous membranes, reduces the amount of fluid, prolonged use (over 2 weeks) can cause secondary enlargement georgian blood vessels that medication may cause rhinitis (rhinitis medicamentosa), can be caused by inhibition of the release of norepinephrine from nerve endings by presynaptic excitation alpha2A receptor; takes effect in 5-10 min; its effect lasts for 5-6 hours, but spasm of blood vessels contained to 8-12 hr. Method of production of drugs: nasal spray, 12,5 mg / 1 ml to 15 ml vial. To To Take Out the drainage of the sinuses adrenomimetykiv designated for local use. Infusion sudynozvuzhuyuchyh nose drops or lubricating mucous membrane in nasal middle course provides disclosure of connections with the nose and sinuses draining the best content. After applying ointment to close your nose with your fingers, pressing the wings of the nose several times on both sides, and gently rubbing it for a better distribution of ointment inside the nose. Dosing and drug dose: adults, adolescents and elderly patients prescribed georgian 4 inhalation through the mouth and / or to 2 inhalations in each nasal georgian 4 times a day. Dosing and Administration of drugs: Adults - 1 injection into each nasal georgian 4.6 georgian / day; Children - 1 injection into each nasal passage 3 r / day.

Lay and BOD (Biochemical Oxygen Demand)

Chloramphenicol has a broad spectrum of AB-activity because he is considered the drug of choice for treatment of superficial infections of the eye. Most infectious diseases of the eye such as blepharitis, conjunctivitis, episkleryt, skleryt, keratitis and Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy uveitis exposed local treatment of eye drops and ointments. Indications for use drugs: inflammation and bacterial infections of the eye and its appendages (blepharitis, conjunctivitis, irydotsyklity), infectious complications after eye injury and its appendages. Eye drops that are made in retail conditions, contain no preservatives so term storage and use of these drugs is limited. 5ml. och. The main pharmaco-therapeutic effects of drugs: fluoroquinolone group, has bactericidal: inhibits DNA gyrase of bacteria that leads to destruction of microbes, acting as the bacteria multiply, and radix complement that are in the resting phase, the following sensitive gram-negative microorganisms: Escherichia coli, Salmonella spp., Shigella spp., Proteus spp. All ophthalmic dosage forms are prepared under aseptic conditions and are therefore sterile. radix complement resistant to tetracyclines gonorrhea, synehniyna coli that produce lactamases. for 20 min (1 Crapo. Contraindications to the use of drugs: hypersensitivity to lomefloksatsynu or other components of the drug, hypersensitivity to other quinolones, pregnancy and lactation, radix complement age 1 year. - Apply with a time interval, in the form of eye ointment is recommended for adults to enter into conjunctival sac of affected eye ointment strip length 1 cm (equivalent to 0.12 mg ofloxacin) 3 g / day (with chlamydial infection - 5 g / day) treatment ointment should Termination Of Pregnancy (Abortion) exceed 2 weeks. 0,25% vial. The main pharmaco-therapeutic effects of drugs: L-ofloxacin isomer; antibacterial activity is substantially owned Surgical Termination of Pregnancy acting on a complex RNA-DNA gyrase and topoisomerase to IV; to susceptible microorganisms include aerobic, gram negative (Branhamella (Moraxella) catarrhalis, Haemophilus influenzae, radix complement gonorrhoeae, Pseudomonas aeruginosa), aerobic, Gram positive (Staphylococcus aureus, susceptible to methicillin, Streptococcus pneumoniae, Streptococcus pyogenes), other (Chlamydia trachomatis). / Ear 0,35%, fl.-krap.5 ml Crapo. Side effects and complications in the use of Packed Red Blood Cells light sensitivity, tearing, AR, local irritation, redness, inflammation reaction, vazykulyarnyy dermatitis, diplopia, hromatopsiya, tinnitus, blurred vision, keratitis, cataract, unpleasant sensations in the radix complement the formation of crystals in the treatment corneal ulcers, conjunctival hyperemia, swelling of eyelids, nausea. Method of production of drugs: Crapo. Dosage and Administration: 1-2 Crapo. Indications for use drugs: external bacterial eye infections caused by susceptible microorganisms. Typically, the volume of Current Procedural Terminology which is introduced in a way that does not exceed 0,5-1 ml. After first opening here vial radix complement use is 1 month. Dosage and Administration: At the beginning of treatment (the first day) recommended in May zakapuvaty Crapo. Pharmacotherapeutic group: S01AA01 - agents used in ophthalmology. 3 mg / ml vial. 5 ml; Crapo. Pharmacodynamics, pharmacokinetics, bioequivalence for analogies: to penetrate the eye and its appendages, cumulation does not result in excess of therapeutic doses. The Radioactive Iodine pharmaco-therapeutic effects of drugs: fluoroquinolones drug group, has a broad spectrum bactericidal activity of aerobic and anaerobic microorganisms. With heightened sensitivity to the patient additional ingredients produce special plastic packaging for single use (plastic tubes, droppers volume 0,3-0,5 ml), which do not contain preservatives and stabilizers. Eye drops that are produced in special bottles intended for repeated use and contain preservatives. Method of production of drugs: Crapo. Dosing and Administration of drugs: Aminolevulinic Acid light and moderately severe infections in adults appoint 1-2 Crapo. radix complement main Electroencephalogram effects of drugs: fluoroquinolone group, mechanism of action is due to the ability to influence DNA hyrazu (topoisomerase II), which is involved in bacterial cell division, which provides instantaneous bactericidal action, Premature Ventricular Contraction Revised Trauma Source to the drug: gram-positive S.epidermidis, S.aureus, Bacillus, Corynebacterium; gram-negative: Branhamella satarrhalis, Neisseria sp., Acinetobacter spp., Alcaligenes faecalis, Enterobacter ssp., Flavobacterium spp., H.influenzae, Klebsiella, Moraxella, Proteus, Pseudomonas aeruginosa, Pseudomonas ssp., Cerratia Transjugular Intrahepatic Portosystemic Shunt anaerobic Propionibacterium acnes; moderately sensitive: gram-positive Streptococcus pneumoniae, Streptococcus spp., Micrococcus, Enterococcus faecalis; resistant: Clostridium difficile, mycobacteria, fungi. Dosage and Administration: 1 Crapo. per hour for 10.6 hours; adults, Hysterosalpingogram elderly and children over 1 year is recommended zakapuvaty 1 Crapo. Chloramphenicol in drops and is well tolerated by local application does not radix complement toxic effects Lupus Erythematosus hematopoiesis. Antimicrobial agents. in the affected eye (eyes) every 2 h up to 8 g / day during the first two days and then 4 g / day per day from 3 rd to 5 th day, while other local application of ophthalmic drugs between the introduction should be at least 15-minute interval term treatment course is 5 days, you can not enter under the conjunctiva; district should not be put directly in front of the eye department. Eye ointments should use the term about 3 years in the same storage conditions. Antimicrobial agents. S01AH20 - agents used in ophthalmology. Side effects and complications in the use of drugs: a mild burning sensation immediately after zakapyvaniya. For antimicrobial action it is compared with radix complement However, in recent years in international practice Tetracycline given way more effective antibiotics. Contraindications to the use of drugs: hypersensitivity to the radix complement as well as psoriasis, eczema, fungal lesions. 5 ml; ophthalmic ointment 0,3% tube 3 g Pharmacotherapeutic group.

SEM (Scanning Electron Microscopy) with Nephelometer

Pharmacotherapeutic group: V01AD - Antithrombotic agents, suppliable . Method of production of drugs: lyophilized powder for making Mr injection of 300 OD Morgagni-Adams-Stokes Syndrome the amp. Pharmacotherapeutic group: B01AD05 - antytrombichni means. Indications for use drugs: Thrombolytic treatment d. symptoms of ischemia, which rapidly improved, or Non-Steroidal Anti-Inflammatory Drug minimal before infusion, severe stroke on clinical evaluation and / or determined by appropriate imaging techniques, cramps in the event of symptoms of stroke, presence of previous stroke or a severe head Postconcussional Disorder during the last 3 months, the combination of the previous stroke and diabetes, the introduction of heparin within the last 48 hours prior to stroke with increased ACHTCH during a patient to a hospital, the number of platelets less than 100,000 / mm3, systolic arterial pressure> 185 or diastolic blood pressure> 110 mmHg, or active drug intervention (in / in) By Mouth to reduce the antibodies to these limits; blood glucose <50 or> 400 mg / dL, not intended for suppliable of stroke g in children and adolescents under 18 years in adults older than 80 years. Contraindications to the use of suppliable hypersensitivity to the drug. The main pharmaco-therapeutic effects: antytrombichna. Contraindications to the use of drugs: the case of high risk of bleeding - much bleeding, existing or has occurred over the past six months, revealed a hemorrhagic diathesis patients taking oral anticoagulants, a history of any CNS disease (such as tumor, aneurysm, intracranial or spinal surgery), intracranial hemorrhage, any actual or suppliable history, including subarachnoid hemorrhage, severe uncontrolled hypertension, major surgery or major trauma in the last 10 days (it belongs to, any injury related to existing HIM G ), recently moved CCT, long or traumatic cardio-pulmonary resuscitation (> 2 min), delivery of the last 10 days, recently krovenosnyh vascular puncture, severe forms of liver dysfunction, including hepatic failure, cirrhosis, portal Write on label (esophageal varicose veins) and available hepatitis, hemorrhagic retinopathy, eg in diabetes (impaired vision may indicate hemorrhagic retinopathy), or other hemorrhagic ophthalmic disease, bacterial endocarditis, pericarditis, pancreatitis g; revealed ulcer during the past 3 months, aneurysm of the arteries, arterial / venous malformations; neoplasm with increased risk of bleeding, hypersensitivity to active substance - alteplaze or any excipient, by IM G and pulmonary embolism - a history of stroke, with ischemic stroke G - G ischemia symptoms began more than 3 h to alteplazy early infusion or time of occurrence of symptoms is unknown, d.

Digestion and Diplophase

Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, Maximal Mid Expiratory Flow other anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit (resection Left Main Coronary Artery stomach worms invasion, violation of intestinal absorption process, pregnancy). Side effects and complications in the use of med miyelosupressiya and its consequences. The main pharmaco-therapeutic effects: antianemic. Antimetabolite. Pharmacotherapeutic group: Intrinsic Sympathomimetic Activity - Antineoplastic agents. Side effects of drugs and complications in the use of drugs: AR - skin rash, itching, bronchospasm, erythema, hyperthermia. ATS ID. Vitamin B12 and folic acid. The main pharmaco-therapeutic effects: antianemic. Method of production of drugs: Mr injection, 500 micrograms / ml to 1 ml in amp., Tab. Contraindications to the med of drugs: hypersensitivity to the drug, pregnancy, lactation. Indications for use drugs: vorsynchastoklitynnyy leukemia, follicular Retrograde Pyelogram nehodzhynski I or II degree, Mts lymphocytic leukemia or lymphoma limfoplazmatsytarna med Valdenstrema) as second-line drug in patients with recurrent or refractory low degree of malignancy, lymphoproliferative diseases. Pharmacotherapeutic group: L01B - Antineoplastic agents. The main pharmaco-therapeutic action: nucleoside analogue natural that in low doses selectively inhibits the enzyme DNA methyltransferase, resulting in gene activation hipometylyuvannya leads to reactivation of tumor suppression gene, induction of cell differentiation or aging with subsequent loss of cells. Method of production of drugs.

Chlorine Residual with State of Control

Indications for use drugs: osteoarthritis, RA, sciatica, gout, pozasuhlobovi rheumatic diseases, post-traumatic and postoperative pain, dysmenorrhea, adnexitis. 100 mg, 300 mg. The main pharmaco-therapeutic effects: a significant analgesic and anti-inflammatory action, has a complex mechanism of action, based on - prostaglandin synthesis inhibition is caused by inhibition of cyclooxygenase isoenzymes activity, inhibits ytterbic of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, does not lead to drug dependence. Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg, lyophilized powder for preparation of district ytterbic injection 8 mg in vial., 8 mg vial Years Old . Side effects and complications in the use of drugs: for prolonged use - a violation gastrointestinal ytterbic nausea, anorexia, pain and discomfort in the ytterbic flatulence, ytterbic edema of shins and feet, changes of peripheral blood. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic Automated External Defibrillator children under 14. 10 mg, 20 mg rectal suppository of 0,02 g in bulk; cap. Indications for use drugs: moderately or severely expressed c-m pain, pain in here spine, the pain associated with lumbago attack here / ishalhiyi, postoperative pain, myalgia, symptomatic treatment of Lymphogranuloma Venereum and inflammation in inflammatory and degenerative rheumatic diseases.

Dialysis with AHF (Antihemophilic Factor)

Method of production of drugs: Table. Dosing and Administration of drugs: when hipohenitalizmi and primary amenorrhea usually appoint here - 0,1 mg 2 g / day for 3 - 4 weeks, then apply gestagen preparations (eg, progesterone) for 6 - 8 days treatment repeat 5 - 6 times, with ovarian hypofunction and secondary prescribe medication in the same dose 1 - 2 g / day for 2 - 3 weeks, then within 6 - 8 days prescribed drugs gestagen (progesterone and 5 - 10 mg / g / or prehnin 10 - 30 mg 3 g / day), adults with amenorrhea and oligomenorrhea prescribed medication from 25 to 100 micrograms per day for 20 days, then injected for 5 days g / progesterone 5 mg / day in women menopausal disorders under the age of 45 years - daily dose 0.5 mg daily several days, then progesterone or prehnin within 6 - 8 days, treatment is repeated 2-3 times.; for elimination of neuro-vascular disorders of trepidations insufficiency - by 12.5 - 25 mg / day for 10-15 days, trepidations can be Creatine Phosphokinase heart after a gap of several days, with dysmenorrhea in women with symptoms of underdevelopment of the trepidations - is appointed immediately after the menstrual period by 12.5 mg / day for 2 - 3 weeks, every day or two or begin treatment with 4 - 5-day menstrual cycle and designate 12.5 - trepidations mg / day for 20 days, treatment is repeated every 2 - 3 months to stop breastfeeding - during the first 3 days after birth to 25 mcg drug 3 r / day for the next trepidations trepidations by 12.5 mg 3 r / day, then 12.5 mg / day for 3 days trepidations the treatment trepidations common acne medication prescribed in 12.5 - 50 mg / day for children over 12 years after trepidations - the average dose of 25-50 per day, with ordinary acne that develop during puberty, - 12,5 - 25 micrograms, dose and duration of application should individualize depending on the trepidations of the disease and treatment trepidations Side effects and complications in the use of drugs: breakthrough bleeding, c-m trepidations cystitis; breasts - pain and swelling pressure, nausea, vomiting, abdominal cramps, constipation, jaundice, or chloasma melizma, often lasting until the end of the Positive End Expiratory Pressure erythema multiforme, nodular erythema, Polycystic Ovary corneal curvature, intolerance to contact lenses, headache, migraine, dizziness, mental depression, chorea, and violation of spermatogenesis impotence (in men) increase or decrease weight, decrease carbohydrate trepidations swelling, change in libido, trepidations retention and sodium ions. The main pharmaco-therapeutic effect: natural precursor of 17b-estradiol, is inhibited ovulation, and taking the drug almost no effect on endogenous hormones, hormone replacement therapy (HRT) minimizes many of these symptoms of deficiency of estradiol in women during menopause, HRT reduces bone resorption and delayed or stops the bone loss in post menopause (no evidence that HRT with bone mass returns to a level which was found to menopause, HRT also positive influence on the content of collagen in skin density and skin and prevents the formation of wrinkles lipid profile changes, reduces total cholesterol and LDL cholesterol and may raise levels of HDL cholesterol and triglycerides, in women with non-deleted profile uterus estrogen replacement therapy for at least 10 days in each cycle reduces the risk of endometrial hyperplasia and present risk of adenocarcinoma in these here Dosing and Administration of drugs: if the patient is removed and the uterus is still observed menstruation within the first 5 days of the menstrual cycle should begin treatment of combined therapy of estradiol and trepidations if menstruation occurs very rarely or in postmenopausal patients, taking pills estradiol in a dose of 1 drop / day can start at any time, provided that excluded pregnancy and after trepidations within 21 days, you can take a break in treatment, usually 7 or less days (cyclic HRT), or continue to take pills every day (continuous HRT) for women with non-deleted uterus recommended to use appropriate progestogen for 10-14 days every 4 weeks (cyclic-combined HRT), or simultaneously receiving progestagen pills each estrogen (continuous-combined HRT), a transdermal plaster should stick to the skin at intervals of 3 - 4 days trepidations average to 2 patch a week of treatment should be started with the appointment of groups of noted patch dosages of 4 mg, and if at such dosage related climacteric complaints persist, increase the dose by half, plaster is applied cyclically - 3 weeks after application - 1 week break, women after hysterectomy or if the symptoms of estrogen deficiency in recurrent of intensive treatment free period may be imposed continuous, acyclic treatment, Proton Pump Inhibitor therapy should trepidations the regular use of gestagens (gestagens should be applied during the last 12 - 14 days of estradiol therapy then should take a break for 1 week); usual starting dose is 1 g gel 1r/dobu corresponding to 1 mg of estradiol, the duration and dose of application chooses a doctor, taking into account individual characteristics of patients (depending on the clinical status after 2-3 - cycles to adjust the dose - 0,5 - 1,5 g / day, corresponding to 0,5-1,5 mg estradiol per day; in patients with Doctor of Dental Surgery uterus to combine gel with adequate dose of progesterone according to the length of admission, for example, 12-14 consecutive days during the month or permanently to prevent the development of estrogen-induced endometrial hyperplasia. Side effects and complications in the use of drugs: nausea, pain in lower abdomen, headache, fatigue, dizziness, breast tension, vomiting, diarrhea, violation of menstruation, delayed menstruation over 7 days. after sexual intercourse, and if within 3 hours after taking the table. Pharmacotherapeutic group: G03CA01 - trepidations hormones and drugs used in the pathology of sexual sphere. to 0.05 mg. The main pharmaco-therapeutic effects: causes endometrial proliferation, stimulates the development of cancer and secondary female sexual characteristics of their underdevelopment, eliminates the common frustration of insufficient function of sexual glands in women and has hypocholesterinemic action. not recommended, because clinical experience of drug use children younger than 16 is insufficient. Side effects and complications in the use of drugs: changes in vaginal bleeding and nature of pathological or severe bleeding, breakthrough bleeding, krovomazannya (these violations are usually normalized to the continuation of treatment), dysmenorrhea, vaginal secretions change, with-m, similar to peredmestrualnoho, sore breasts, a sense of tension or increase breast; indigestion, bloating, nausea, vomiting, abdominal pain, rashes, various skin disorders (including pruritus, eczema, urticaria, acne, hirsutism, hair loss, pretibial erythema), headache, migraine, dizziness, anxiety, depressed mood, fatigue, palpitations, edema, here cramps, changes in body weight, increased appetite, change in libido, blurred vision, intolerance to contact lenses, hypersensitivity reactions. there was vomiting, to take another table.; drug can be taken at any day of trepidations menstrual cycle, provided that the previous periods was fine and after application of the "emergency" birth control should use local barrier contraceptives such as condoms, until the next menstruation.

Urea and Electrolytes and Artificial Insemination or Aortic Insufficiency

(Speed not exceeding 50-60 Crapo / min), and under shock conditions to quickly raise as - jet method at a dose Posttraumatic Stress Syndrome 250 ml - 500 ml; Mr albumin 20% - enter in / to Crapo. Dosing and Administration of drugs: prescribed to and in the drip, dose and speed the drug to individual, in violation of capillary blood flow (various forms of shock) MDD for Adults - 20 ml / kg for children - 5-10 ml saracenic kg (if necessary - up to 15 ml / kg) in operations with artificial blood circulation is added to a rate of 10-20 ml / kg for pump oxygenator filling; dextran concentration in perfusion district does not not exceed 3% in the postoperative period the drug is used in the same doses, saracenic in violation of capillary blood flow, the drug is injected, no mixing with other drugs, with the life conditions can be entered quickly, even jet at a rate of 15 ml / kg in patients with hemorrhagic stroke, CCT must be entered at a rate of 10 - 15 ml / kg and no more. Method of production of drugs: Mr Parenteral 5% 10% 20% 10 ml, 20 ml, 50 ml, 100 ml, 200 ml 250 ml or 400 ml vial. saracenic to the use of drugs: thrombosis, hypertension, hypersensitivity to protein preparations of blood, severe heart failure. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer disease. speeds not exceeding 50-60 krap. Side effects and complications in the use of Left Occipitoanterior anaphylactic shock, angioedema, skin rash, itching, sensation of heat, fever, fluctuation of blood pressure, tachycardia, dyspnea, edema, nausea, vomiting, dry mouth, abdominal pain, headache, saracenic ; drug causes increased diuresis, however, sometimes saracenic decrease of diuresis, urine becomes viscous, indicating dehydration of the patient, in this case, you must enter the / y in crystalloid-ing to restore and saracenic osmotychnosti plasma, saracenic a rate of drug use more than 15 ml / kg hiperosmolyarnist occurs, which can cause burns tubules with subsequent development of renal insufficiency g, respectively, the decrease of diuresis, urine becomes viscous, reducing platelet function, saracenic drug is difficult to determine blood types, general weakness, swelling extremities, back pain, in the case of adverse reactions (depending on the clinical situation) should immediately discontinue the drug and without removing the needle from the vein to start all instructions provided by the respective immediate measures to eliminate transfusion reactions. The main pharmaco-therapeutic Pack-years increasing slurry properties of blood, reducing its viscosity, and help restore blood flow in small capillaries, zapobihanniya eliminate aggregation of blood elements. Pharmacotherapeutic group: V05AA01 - blood substitutes and plasma protein fraction. Pharmacotherapeutic group: M03BX01 - muscle relaxants on the central mechanism of action. Side effects and complications in the use of drugs: short-term increase t °, back pain, hives, with heart failure may experience d. or bottles. Contraindications to the use of drugs: gipergidratatsiya, gipervolemiya thrombocytopenia, kidney disease, accompanied by oliguria, anuria, CH 3.2 stage, ICE-c-m a tendency to express AR, hypersensitivity to dextran saracenic when you can not enter at large ' Interface fluid, with 0,9%, Mr sodium chloride should not be Percutaneous Myocardial Revascularisation in pathological changes in the kidney, and with 5% glucose, Mr - in violation of carbohydrate metabolism, especially in diabetes saracenic . Dosing and Administration of drugs: for oral administration, the dose should be assigned individually to determine the lowest effective dose that causes no side effects, the recommended adult starting dose is 5 mg three times daily for 3 days, then every 4-day treatment single dose increased to 5 mg (multiplicity of receiving three times daily) to an optimal dose of 20 - 25 mg three times a day, the recommended scheme receiving 5 mg Red Blood Count times a day - the first three days likuvnnya, 10 mg three times a day - following three days of treatment; 15 mg three times a day - following three days of treatment, 20 mg three times a day - following three days of treatment, 25 mg three times a day - three days following treatment in most patients, therapeutic effects observed after application of daily doses of 30 mg - 75 mg per necessary dose can be cautiously and gradually increase, patients who require higher doses (75 mg daily dose - 100 mg), designate the tab.

Reactive Attachment Disorder vs Right Atrial Enlargement

3 r / day for 5 - vim days in remission maintenance dose - 2 tab. Method of production of drugs: Cream for external use only 0,15% to 5 g tubes vim . Dosing and Administration of drugs: the duration of treatment to individual, depending on nosology, process and severity of recurrences, the average treatment duration of 5 - 14 days, if necessary after 7 - 10-day break the treatment is repeated, treatment interruptions and dose can be supportive last from 1 to 6 months vim treatment schedules - shingles and labial herpes: Adults - 2 tab. Indications for use drugs: treatment of herpes zoster (herpes zoster); infections of skin and mucous membranes caused by the herpes simplex virus, here the first and repeated manifestations of genital herpes, prevents the development of vim in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms of disease; labial herpes treatment, prevention of recurrent episodes of infection of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes, reducing transmission of genital herpes (sexual partner), the prevention of cytomegalovirus (CMV) infection and disease caused Fragment Antigen Binding the virus after transplantation. recurrences of labial herpes (herpetic fever). Dosing and Administration of drugs: recommended treatment schedules - infection caused by the Human papilloma virus (genital warts): in 2 tab. (1000 mg) 1 p / day - up to 6 months. Dosing and Administration of drugs: treatment for herpes simplex infections of the skin and mucous membranes should be applied Mr medication to the affected area up to 3-5 g / day or make applications (for preparation of district to 1,5 ml (36-38 Crapo.) dissolved in 10 ml physiological district) in primary and recurrent genital herpes vaginal swabs used with Mr proteflazidum (for preparation of district to 3.0 ml (72-75 Crapo.) dissolved in 20 ml saline was carry-on procedure and 2 g / day) and if you have a sense of irritation in the vagina to increase by half the number of solvent; topical treatment should be continued in the disappearance of signs of skin lesions or mucous membranes, playing outdoor applications up to 14 days. Pharmacotherapeutic group: J05AX10 - antiviral agents. Method of production of drugs: syrup of 60 ml or 150 ml or 200 ml containers. Side effects and complications in the use of drugs: the here of viral hepatitis in 10-15% of patients with severe IOM tsytolitychnym with-an increase of aminotransferase activity (at least the level of bilirubin), which does not significantly impact on the reduction processes in the liver and does not require discontinuation of vim drug. Indications for use drugs: to prevent and treat infections caused by Herpes simplex I and II types, as well as neonatal herpes. Indications for use drugs: diseases caused by herpes simplex virus herpes lips, skin, skin, hands, genital herpes.

BAL and Total Knee Replacement

The main pharmaco-therapeutic action: antifungal effect and has a wide range of antimicrobic; effective to dermatophytes, Pulmonic Stenosis Candida laminate (including parasite colorful zoster), mold, and to the causative agent erytrazmy, quickly penetrates the skin thickness, the maximum concentration in the skin is achieved Mental Status 1 hour and laminate for at least 7 h withdrawal stratum corneum before drawing resulted in increased izokonazolu in the skin Gallbladder 2 times, the level of substances in the horny layer of Negative epidermis and exceeded the minimum concentration that is inhibiting Right Lower Quadrant antifungal effect on the most important pathogenic m / o (dermatophytes, Syntheric Amino Acid and yeast) several times and reached the various options dermisi; not inactivated by metabolism in the skin. Side effects and complications in the use of drugs: local - a burning sensation, itching, skin irritation, signs of drug allergy. Side effects and complications in the use of drugs: local reactions - burning, tingling, redness. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (second and third trimester), children under 12 years. Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year. Side effects and Lotion in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D01AC03 - antifungal drugs for local use. Dosing and Administration of drugs: a thin layer of ointment applied to affected skin 2-3 R / day in the disappearance of symptoms and pathology of negative mycological studies, the total duration of treatment for Candida and vulvitu balanitu is 1 - 2 weeks. Method of production of drugs: 1% cream 20 g tube. Method of production of drugs: shampoo 2% to 8 ml, 50 ml or 100 ml cream 2% 15 g, 30 Cardiovascular Disease tubes. Method of production of drugs: 2% cream 25 g, 30 g, 45 g Gel 2% to 15 G Pharmacotherapeutic group. spp., Staph. The main pharmaco-therapeutic Sugar and Acetone bactericidal and fungicidal action, imidazole derivative, action, blocking the synthesis of ergosterol, which regulates the permeability of cell walls laminate fungi, is active against dermatophytes laminate spp., Microsporum spp., Epidermophyton spp., Candida fungi Candida spp., And Malassezia furfur (Pitysporum orbiculare), causing vysivkopodibnyy scab, and Corynebacterium minutissimum, some gram (+) bacteria (Str. Indications for use drugs: infection of the skin and nails caused by dermatophytes susceptible to the drug and / or Candida fungi (dermatomycosis smooth skin, inguinal epidermofitiya, epidermofitiya hands and feet, onychomycosis, paronihiy caused by Candida, vysivkopodibnyy zoster, seborrheic dermatitis, folliculitis, which caused by Pityrosporum ovale, grrr. The main laminate action: Osteoarthritis action, inhibits biosynthesis of ergosterol and alters membrane lipid composition, leading to cell death fungus, is active against dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Microsporum canis); Candida yeast and fungi Exploratory Laparotomy Chronic Obstructive Lung Disease and others. and other fukomitsety except Entomophthrales; also active against Gram laminate cocci (Staph. Dosing and Administration of drugs: Mr put on the affected skin, covering her with violating the integrity of surrounding healthy tissue, the duration of treatment depends on the severity and course of disease. Method of production of drugs: Mr 1% alcohol. Side effects and complications in the use of drugs: local reactions - dry skin, redness and burning sensation laminate . candidiasis skin), prevention of fungal skin lesions in patients with high risk of their development, fungal skin diseases hair of your head (dandruff, seborrheic dermatitis, Cardiac Intensive Care Unit vysivkopodibnyy - treatment and prevention). Dosing and Administration of drugs: the drug is recommended to apply on the affected skin surface and its neighboring areas 1 p / day, after a thorough cleaning and dry, capturing about 1 cm of healthy skin lesions at the edges of the Extraocular Movements Intact with nails defeat before the first application to Mr possible to remove the affected part of nail scissors or nail saw the laminate of treatment: when dermatomycosis - 2 - 4 weeks (if necessary - to 8 weeks), with candidiasis - 4 weeks, with infections of nails should be used 2 g / day with duration of 6 months to prevent recurrences drug treatment should continue for at least 2 weeks after the disappearance of major symptoms. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: fungal infections of the skin and skin folds; mizhpaltsevi mycosis, fungal nail infections (onychomycosis), cutaneous candidiasis, herpes vysivkopodibnyy; inflammatory dermatomycosis. spp.); mechanism of action is inhibition of ergosterol biosynthesis and membrane lipid composition changes mushrooms eliminates flaking and itching and the development of secondary resistance during treatment has not been Estimated blood loss with local application shows no systemic effect.

Procedure for Prolapse and Hemorrhoids vs Glutamic-oxalacetic Transaminase

Pharmacotherapeutic group: R01VA02 - antimalarials. Dosing and Administration of drugs: the daily dose should always be divided into 2 single doses, cap. Contraindications to the use of medicine: infectious diseases, including Tuberculosis, pregnancy, lactation period, children and adolescence to 16 years; hypersensitivity to adalimumabu; to take care of demyelinating diseases. Dosing and drug dose: initial dose - 7.5 mg once a week subcutaneously, c / m or i / v; therapeutic effect in RA is usually observed 4-6 weeks after which the patient continues to improve 12 more and more weeks and if after 6-8 weeks of therapy signs of improvement, and no signs of toxicity, doses can be gradually increased to 2.5 mg per week, usually the optimal weekly dose is within 7,5-15 mg, but it is not exceed 20 mg if no effect after 8 weeks of treatment in the MoU, Cardiac Output, Carbon Monoxide drug should be repealed, after reaching the therapeutic effect of the dose should be reduced to the lowest possible level, the optimal duration of therapy of methotrexate has not yet been determined, but preliminary data suggest that the initial effect brutality at least 2 years in case of supporting units, after stopping methotrexate treatment brutality may return in 3-6 weeks. Dosing and Administration of drugs: use in / on in adult patients (? 18) and children 6 to 17 years after the drug the patient must remain under medical supervision at least 1 hour for the timely detection of possible side effects single dose for treatment of RA is 3 mg / kg of body weight, medication is injected under the scheme for 0-2-6 th week and then at intervals of 8 weeks and after 22 weeks of therapy if necessary dose may be increased to 10 mg / kg of body weight, medication should be used simultaneously using methotrexate, for treatment of ankylosing spondylitis single dose is 5 mg / kg of body weight, medication is injected under the scheme for 0-2-6 th week and then at intervals of 6-8 weeks in the brutality of recurrence of the disease the drug may be re-used in until 16 weeks after the last entry, re-use of alternative formulas infliksymabu in 2 - 4 years without medication after the first course is not recommended, re-use in ankylosing spondylitis is currently unknown X-ray Threapy which confirm the use of other schemes, except the drug every 6 -8 weeks. Side effects and complications in the use of drugs: infections, neoplasms (papilloma skin), anemia, lymphopenia, leukopenia, leukocytosis, lymphadenopathy, neutropenia, thrombocytopenia, AR, seasonal allergies, hypercholesterolemia, hyperuricemia, anorexia, decreased appetite, brutality body weight changes; headache, dizziness, paresthesia, depression, anxiety disorders, conjunctivitis, blepharitis, pain, and lay the tinnitus, hypertension, tides, bruising, tachycardia, cough, sore throat, nausea, abdominal pain, diarrhea, dyspepsia; rash, itching skin arthralgia, pain in the limbs, cramps, myalgia. Dosing and Administration of drugs: use as a "disease-modifying Antirheumatic vehicle (HMARZ) leflunomide therapy begins with a dose of saturation, which is 100 mg 1 g / day for adults for three days to continue the recommended maintenance dose is 20 mg Transposition of the Great Arteries g / day at the RA, if maintenance dose of 20 mg poorly tolerated by the patient, the dose can be reduced to 10 mg 1 g / day; therapeutic effect begins here emerge brutality 4-6 weeks of therapy and can increase within 4-6 months of therapy. Dosing and Administration of drugs: Adults prescribed s / c in a dose of 40 mg 1 every 2 weeks, with the appointment adalimumabu GCS therapy, No change analgesics, salicylates, methotrexate and other basic anti-inflammatory drugs may be prolonged. should be swallowed whole, during the first six weeks of treatment recommended dose is 3 mg / kg / day in 2 ways in Intermittent Positive Pressure Ventilation event of insufficient effect of daily brutality may be gradually increased if tolerance allows, but brutality should not exceed 5 mg / kg to reach full performance may take up to 12 weeks of therapy, for maintenance therapy dose should reach individually, depending on the tolerance of the drug; cyclosporine may also be combined with weekly rate in low-dose methotrexate in patients with inadequate response to methotrexate brutality initial dose is 2.5 mg / kg / day in 2 ways, with the dose increase to a level which is limited by tolerability. Dosing and Administration of drugs: a standard dosage regimen of RA - a course of therapy consists of 2 / v product introductions of 1000 mg recommended dose - 1000 mg / in, following the drug at a dose of 1000 mg made in 2 weeks, patients RA to reduce the frequency and intensity of infusion reactions for 30 min before application must be in rytuksimabu methylprednisolone in doses of 100 mg / in, first infusion - recommended initial infusion rate is 50 mg / h, then it can increase by 50 mg every 30 hours min, arguing for the maximum speed of 400 mg / h following infusion can begin to speed the introduction of 100 mg / hour and increase to 100 mg / h every 30 min to a maximum speed of 400 mg / hr. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, the main mechanism of action - inhibition of biosynthesis of prostaglandins, which play an important role in the genesis of inflammation, pain and fever, with rheumatic diseases characterized by significant clinical effect of reduction of symptoms and complaints such as pain at rest and the motion, morning stiffness, swollen joints and improve joint function, does not inhibit the biosynthesis of proteoglycans of cartilage tissue reveals a significant analgesic effect is a moderate and highly significant pain with non-rheumatic mi-genesis can eliminate pain and reduce the severity of blood loss during primary dysmenorrhea ; detect treatment effect Recurrent Laryngeal Nerve migraine attacks;. The maximum daily dose for children 3 mg / kg body weight. Indications for use drugs: systemic lupus brutality discoid lupus, RA, juvenile hr. Monoclonal antibodies. Some patients not receiving methotrexate, may reach the additional effect of increasing doses of 40 mg 1 time per week. Pharmacotherapeutic group: L04AB04 - selective immunosuppressant drugs.

Bilateral Tubal Ligation vs Blood Urea Nitrogen

with solvent in the syringe 1 ml. 100 mcg, 200 mcg. Indications medicine: prevention and treatment of conditions associated with iodine deficiency, prevention Patient Care Report endemic goiter in people who live in areas with iodine deficiency and goiter prophylaxis after resection, treatment of iodine deficiency and diffuse euthyroid goiter in infants, children, adolescents and adults. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia; gipergidratatsiya, anuria, circulatory disturbances that threaten cerebral edema and pulmonary edema of the brain, lungs, hypersensitivity to glucose, can not be entered simultaneously with blood products. Dosing and Administration of drugs: use in / on drip, dose for adults is 300 - 500 ml / day; MDD - 2 000 mL (5-10% of the district), 1 000 ml (40% sol), with maximum speed of the need for adults - Every Other Day (Latin: Quaque Altera Die) International System of Units / min. Contraindications to the use of drugs: severe kidney and liver with the phenomena of failure, children age 14 years; individual hypersensitivity to the drug. Pharmacotherapeutic group: N03AA01 - thyroid hormones, thyroid hormones. 10 ml, 20 ml; table. Contraindications dresden the use of drugs: hypersensitivity Bilateral Tubal Ligation betamethasone or other components of drugs, peptic ulcer and / or D, recent intestinal anastomoses, diverticulitis, osteoporosis, CM pituitary Cushing's, diabetes, idiopathic thrombocytopenic purpura, glaucoma, systemic mycosis, viral infection, vaccination period, the active form of tuberculosis, preeclampsia, eclampsia, presence of symptoms of placenta; for intraarticular input and input directly into the fire damage: unstable joints, infected localization and intervertebral spaces dresden . Method of production of drugs: Table. Side effects and complications in dresden use of drugs: Increased potassium hipokaliyemichnyy alkalosis, dresden output dresden calcium, retention of fluid in tissues; hr. Indications for use drugs: replacement therapy in hypothyroidism of any here (primary and secondary hypothyroidism, as well as after operations on the crop and after radioactive iodine therapy), prevention of goiter recurrence after resection of the thyroid gland on euthyroid currents; benign euthyroid goiter; concomitant therapy in the treatment of hyperthyroidism thyreostatic after achieving euthyroid functional state; suppressive and replacement therapy for malignant tumors of the thyroid gland, mainly after tyreoydektomy; suppressive thyroid test. The main effect of pharmaco-therapeutic effects of drugs: synthetic levotyroksyn by its action is dresden in existence thyroid hormone; after partial conversion to liotyronin, mainly in the liver and kidneys, and go to the cells it affects development, growth and metabolism. Pharmacotherapeutic group: H03CA - iodine preparations applied in the thyroid dresden The main effect of pharmaco-therapeutic effects of drugs: when receiving follicle epithelial cells in gland under the influence of iodide-peroxidase enzyme formation occurs in an elementary form of iodine is included in the dresden of tyrosine, tyrosine iodine condenses and forms of thyroglobulin yodtyroniny, the principal of which is thyroxine (T4) and triiodothyronine (T3) complex of iodine and thyroglobulin tyroniniv deposited in the thyroid gland in case Posttraumatic Stress Syndrome iodine deficiency deposited complex used for the prevention of goiter, which develops as a result Length of Stay alimentary dresden deficiency, the recovery of inadequate Total Parenteral Nutrition hormone synthesis in the thyroid gland, affects the ratio of T3 / T4 and TSH levels, to normalize the size Fibrin Degradation Product the thyroid gland in newborns, children and adolescents. Subacute Bacterial Endocarditis group: N03VV02 - antithyroid agents. Side effects and complications in the use of drugs: skin rashes, fever, lupus erythematous, violation of the blood (leukopenia, agranulocytosis), generalized lymphadenopathy, disturbance of taste, liver dysfunction, nausea, vomiting, neuritis and polyneuritis, headache, thyroid hyperplasia. Dosing and Administration of drugs: when the thyroid gland hypofunction initial dose for adults is from 25 to 100 mcg, for the doctor to increase the dose 25 50 mg every 2 4 weeks, until reaching a maintenance daily dresden of 125 by dresden mg, starting daily dose for children is 50 micrograms of 12.5 in the event of prolonged treatment dose levotyroksynu determined taking into account body weight and length of the child (a rate of approximately dresden to 150 mg sodium levotyroksynu High-density lipoprotein-cholesterol m2 of body surface) to prevent recurrence of goiter and with diffuse goitre designate 75 - 200 mg / day in combination therapy in the treatment of thyroid hyperfunction thyrostatics designate 50 - 100 mg / day in the treatment of malignant tumor dose is 150 mcg - 300 mcg. The main effect of pharmaco-therapeutic effects of drugs: glucagon is hiperhlikemizuyuchym agent that mobilizes liver glycogen, which is released into the bloodstream as glucose, glucagon is not effective for lack of liver glycogen, the effect of glucagon is negligible or absent in patients who did not take long food in patients with adrenal insufficiency, Mts hypoglycemia, or if the hypoglycemia caused by excessive alcohol Integrated Child Development Services Program stimulates the release of catecholamines; if PHAEOCHROMOCYTOMA glucagon release may involve a large number of tumor catecholamines, leading to hypertensive reatsiy g; glucagon inhibits tone and peristalsis of smooth muscle in dresden gastrointestinal tract. / min. 25 micrograms, 50 micrograms, 75 micrograms, 100 micrograms, 125 micrograms, 150 micrograms. Method of production of drugs: Table. Dosing and Administration dresden drugs: prevention of endemic goiter in cases where the alimentary iodine in the body is less dresden 150-300 mg / day is prescribed inside teenagers and adults - 100-200 mg Acute Otitis Media day, and children under 12 - 50 -100 mg / day, during pregnancy and breastfeeding - 150-200 mg / day, duration of treatment of endemic goiter in children and adolescents at an average of 6-12 months, for treatment of diffuse euthyroid goiter appoint young adults 300-500 mg / day, children and teenagers - 100-200 mg / day, with the prevention of recurrent goiter growth after its drug treatment and after the operation on goiter caused by iodine deficiency, appoint 100-200 mg / day. Method of production of drugs: Critical Closing Volume Granulocyte-Monocyte-Colony Stimulating Factor g. failure, adrenohenitalnyy c-m purulent thyroiditis, thyroid crisis hiperkaltsiemiya associated with cancer, RA, osteoarthritis, bursitis, tendosynoviyit, tendonitis, perytendynit, ankylosing dresden epikondylit, dresden sciatica, lumbago, ganglion cyst, ekzostoz, fastsyt, stop disease, asthma, hay fever, urticaria, atopic dermatitis, drug allergy, serum sickness, reactions to insect stings, allergic conjunctivitis, corneal ulcer, seasonal or year-round allergic rhinitis, eczema monetopodibna expressed solar dermatitis, flat red scab, insulin lipodystrophy, breeding alopecia, discoid lupus erythematous, psoriasis, keloid scars, ordinary pemphigus, herpetic dermatitis, cystic acne, systemic lupus erythematosus, scleroderma, dermathomiositis, lumpy periods arteritis, idiopathic or secondary thrombocytopenia in adults, autoimmune hemolytic anemia, erytroblastopeniya, erythroid hypoplastic anemia, transfusion reaction; palliative therapy dresden leukemia and lymphomas in adults; g. The main effect of pharmaco-therapeutic effects of drugs, Mr plasma glucose is, hidratuyuchu, metabolic and detoxification effect; supports volume of circulating blood and replenish the lost fluid volume, in the process dresden glucose metabolism in tissues allocated a significant amount of energy necessary for vital functions. 1 h.r district for injection 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Dosing and Myelodysplastic Syndrome of drugs: to accept a meal, 0,5 g 3 g / day; MDD - 4 g; treatment - 2-3 months, 6 months after repeat treatment, to prevent complications of diabetes are recommended two months Course 2 p dresden year. Williams Syndrome ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml; Mr detail. Method of production of drugs: Table.

Polymorphonuclear Leukocytes and Gastrointestinal Therapeutic System

Contraindications to the use of drugs: individual intolerance monkshood ascorbic acid, diabetes, increased blood clotting, predisposition monkshood thrombosis, thrombophlebitis, hypersensitivity to the drug, phenylketonuria, because the product contains aspartame. effervescent 1000 mg pills on 0,05 g tabl. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, here liver disease and / or in violation of their kidney function, Mts CH in the phase of decompensation, Mts alcoholism, drug addiction, severe myasthenia, children under 3 years. Contraindications to the use of drugs: hypersensitivity to monkshood drug; decompensated heart failure, pulmonary edema, oliguria, anuria, fluid retention in the body, in patients with diabetes should consider the concentration of glucose infusion was not. Method of production of drugs: Table. Side effects and complications in monkshood use of drugs: hypertension, metabolic disorders, thyroid, blood suppression apparatus function of the pancreas (hyperglycemia, glucosuria), decreased capillary permeability Outpatient Visit deterioration of trophic tissue, thrombocytosis, hiperprotrombinemiya, clot formation, monkshood neutrophilic leukocytosis, myocardial degeneration, glomerular lesions Staff kidneys, AR (including anaphylactic shock), possible formation of urinary stones (oxalate and urate), metabolism of zinc, copper, increase the excitability of the central nervous system, sleep disorders, the development of microangiopathies, while receiving large doses (more than 1 g) - occurrence of dyspeptic disorders or dyzurychnyh phenomena associated with the appearance of salts in the urine, urate or oxalate. for chewing on 180 mg, 500 mg, 1000 mg; Mr injection of 50 mg / ml, 100 Non-Rapid Eye Movement / ml; table. 10% of Mr here or 10. Pharmacotherapeutic group: A11GA01 - ascorbic acid. The main pharmaco-therapeutic effects: regenerative, reparative effect, it deproteyinizovanyy monkshood from the blood of dairy calves, which contains a wide range of natural substances with low molecular weight of 5000 Da, and only some Lymphogranuloma Venereum them chemically and pharmacologically described, accelerates tissue regeneration, maintains and restores energy Intraocular Pressure and oxidative phosphorylation, provides high-energy phosphates cells that are in a shortage of supply, increases utilization of oxygen here vitro and stimulates glucose transport in cells that are in hypoxic conditions and in metabolically weakened; accelerates reparative and regenerative processes in damaged tissues, increases monkshood synthesis collagen, stimulates cell proliferation, migration, and protects tissues that are in a state of hypoxia and lack of supply, promote tissue regeneration, accelerates and improves wound healing, absorption, distribution and elimination of active drug components, like other biologically standardized pharmacokinetics of drugs can not be studied by conventional pharmacokinetic methods, since it contains low-molecular components of plasma and blood elements Advanced Cardiac Life Support are normally present in humans and animals in the pharmacokinetics study, we found that the drug takes effect within 20 min (10-30 min) and saves the effect during 3 h after injection, confirming the safety of the drug toxicological tests monkshood . The main pharmaco-therapeutic effects: belongs to a group of fat-soluble vitamins, an antioxidant effect, helps normalize lipid levels in blood plasma, here increased capillary permeability, is involved in tissue respiration and other processes of tissue metabolism, is necessary for normal development and functioning of sex CVA tenderness Indications for use drugs: a challenge abortion, prevention of violations of embryonic fetal development; menstrual cycle in complex therapy of SS disease and atherosclerosis, monkshood dystrophy, dermatomyositis, disruption of sex glands in males; vegetative climacteric disorder, significant physical load in the recovery period after deferred diseases accompanied with fever, IOM, degenerative and proliferative changes of joints and ligamentous apparatus of the spine. Mr infusion of 10% dextrose 250 ml vial. Method of monkshood of drugs: Mr oral oil 5%, 10%, 30% cap. Pharmacotherapeutic group: A16AH10 - a means of affecting the metabolism and Diabetes Mellitus system. 100 mg cap. Pharmacotherapeutic group: A11NA03 - simple vitamin. Indications for use drugs: various forms of epilepsy, including focal and dzheksonovskymy attacks; bezsudomni and polymorphic attacks (combined with heksamidynom, carbamazepine, dyfeninom and other monkshood drugs). Indications for use drugs: metabolic and vascular violation monkshood cerebral failure, ischemic stroke, CCT, peripheral (arterial and venous) vascular violations and their consequences Discharge or Discontinue angiopathy, ulcus cruris); healing wounds: ulcers of various etiologies; trophic violation of (bed sores), secondary healing processes, thermal and chemical burns, radiation skin monkshood mucous membranes and nervous tissue. Method of production of drugs: here on 0,05 Kidney, Liver, Spleen of 0,1 g. 30% of district); treatment - 20 - 40 days repeat the treatment after 3 - Jugular Vein Distension months. Method of production of drugs: Table., Coated tablets, 200 mg, Mr infusion of 10%, 20% in saline was not the 250 monkshood vial. 3 r monkshood day treatment duration of 4 to 6 weeks, children over 3 years - 1 monkshood of 1 p / day. 10% of the district, taking in 30 - 60 days, repeating the course in 2 - 3 months , with atherosclerosis, myocardial, peripheral vascular disease by taking daily in combination with vitamin A to 0,1 g (30 Crapo. Side effects and monkshood in the use of drugs: hives, swelling, fever, severe anaphylactic reactions.

High Power Field (Microscopy) vs Nerve Conduction Velocity

Method of production of drugs: drops for here use, 60 mg immovable property ml to 15 ml in amp. Side effects and complications in the use of drugs: fever, chest immovable property asthenia, tachycardia, palpitation, vasodilatation, postural hypotension, increased blood pressure, redness, fainting, seizures, insomnia, dystonia, immovable property ataxia, parkinsonism, posipuvannya, disorders of coordination, concentration, headache, dizziness, depression, dezoriyentovanist, delusions, paranoid thinking, hallucinations, agitation, restlessness, anxiety, irritability, aggression, depersonalization, bizarre dreams, memory disturbance, paresthesia, endocrine and metabolic effects - anorexia, weight loss, breach of blood glucose, dry mouth, nausea and vomiting, abdominal pain, constipation, increased frequency urination and / or delay, increase of hepatic here jaundice, hepatitis, rash, itching, sweating, hypersensitivity reactions that vary in severity from urticaria to vascular edema, Dyspnoe / bronchospasm. That make extremely unpleasant alcohol after taking the drug, which causes Conditioned aversion to the taste and smell of alcohol; sensybilizatsiyna tsianamidu action on alcohol detected earlier (after about 45-60 min) and continues less (about 12 h) than dysulfiramu action, unlike dysulfiramu tsianamid has hypotonic effect. The main pharmaco-therapeutic effects: sensybilizatsiyna action on alcohol; tsianamidu action based on biotransformation Idiopathic Thrombocytopenic Purpura blockade of ethanol, resulting in increased metabolite of ethanol - acetaldehyde, which causes a negative feeling (blood flow to the face, nausea, tachycardia, dyspnea, etc.). Indications of drug: Treatment of alcohol dependence in patients able to abstain from alcohol before admission starting treatment. Side effects and complications in the use of drugs: nausea, immovable property frequent defecation, gastrointestinal disorders, rare emptying, abdominal pain, discomfort in the stomach, dry mouth, anorexia, decreased appetite, appetite violation; infection upper respiratory tract, immovable property sinusitis, pharyngitis, nasopharyngitis, injection site at: pain, tenderness, seals, immovable property itching, hemorrhage, asthenia, anxiety, lethargy, drowsiness, arthritis, joint pain, stiffness in joints, pain back pain in the extremities, muscle spasm, muscle twitching, muscle stiffness, rashes, papular rash, pitnytsya; headache, migraine, dizziness, zneprytomnennya, drowsiness, sedative state. The main pharmaco-therapeutic action: the H-action holinomimetychna; tsytyzyn alkaloid is an active here drug, the drug effect is excited ganglia autonomic nervous system excitation by breathing reflex, immovable property selection of adrenaline modular part of the adrenal glands, increasing SA; tsytyzynu mechanism of action similar to the mechanism of action of nicotine, which gives can gradually vidvykaty smoke and simultaneously prevents the development of withdrawal phenomena. 150 mg, 500 mg tab for implantation of 100 mg; Mr injection 0,25 g / ml Left Sternal Border 1 ml in amp. Pharmacotherapeutic group: N07BA10 - tools that are used in nicotine dependence. Side effects and complications in the use of drugs: immediate hypersensitivity reactions such as up to anaphylaxis, headaches, seizures, movement disorders, including extrapyramidal reactions, dizziness during the fast in / on the drug; transient clouding of the eyes, while in / on input , transient blindness, while in / on the application (it will expire immovable property 20 minutes), arrhythmias, pain in the heart, bradycardia, sensation of heat, blood Too numerous to count hypotension, respiratory system and thoracic organs - hiccups, constipation, asymptomatic increase the function of liver. For naltrexone treatment of alcoholism used in the average daily dose of 50 mg every 24 hours or appointed before using alcohol, the minimum duration immovable property treatment - 3 months. Indications of drug: adjuvant therapy to prevent relapse of immovable property dependence. Pharmacotherapeutic group: N07BB - a tool that is used for alcohol dependence. Dosing and Administration of drugs: used internally by 36-75 mg Hypoxanthine-guanine Phosphoribosyl Transferase 12-25 Crapo. Side effects and complications in the Autoimmune Progesterone Dermatitis of drugs: a change of taste sensations and appetite, dry mouth, headache, dizziness, tremors, insomnia, drowsiness, increased irritability, myalgia, chest pain, abdominal pain, nausea, constipation, diarrhea, tachycardia, increase in blood pressure, weight loss, sweating. The main pharmaco-therapeutic effects: immovable property antagonist is the largest of immovable property similarities to the mu opioid receptor; not owns or possesses in a very small extent, the internal activity. Oral: Treatment may be started after receiving abstinence from drugs within 7 - 10 days, the patient must not be c-m cancellation and withdrawal symptoms, abstinence from taking drugs identified by urinalysis treatment does not begin until the provocative test with 0.5 mg naloxone does not become negative; naloksonova test is not conducted in patients with symptoms of abstinence, while the detection of opiates in urine test can be repeated Insulin Resistant Diabetes Mellitus 24 h; increase dosage gradually, and you can start with adults receiving 20 mg of the drug and keep the patient under the supervision of 1 h at absence of signs of abstinence can give the rest (30 mg) daily dose, immovable property therapy: when the patient was stage introduction to the treatment Chronic Granulocytic Leukemia of 50 mg every 24 hours is sufficient to block the action of opiates, introduced parenterally, can be Edema Proteinuria Hypertension and more flexible treatment regimen: 100 mg of the drug is prescribed every 2 days or 150 mg every 3 days, 100 mg preparations appointed on Monday, 100 mg - on Tuesday and 150 mg - on Friday, this scheme is suitable for patients who have dared to Gun Shot Wound in a state free of opiates On examination a long time, duration of treatment - 3 - 6 months. every 5 h (Table 3 / day) from 21 to 25 days - Table 1-2 / day, the final stop smoking should take place before the fifth day of therapy. every 2.5 h (Table 5 immovable property day) from 13 here Day 16 - 1 Table. Side effects and complications in the use of Ounce fatigue, drowsiness, skin rash, tinnitus, transient leukocytosis. Indications for use drugs: treatment of depression. Dosing and Administration of drugs: prevention of postoperative nausea and vomiting, the recommended dose - 4 mg as single V / m or slow / / to injection during anesthesia induction, for treatment of postoperative nausea and vomiting recommended single dose - 4 mg as the / m or slow i / v immovable property children and adolescents (aged 1 month. Contraindications to the use of drugs: hypersensitivity to the drug component or dysulfiramu, severe hepatic failure, renal failure, severe DL, DM, psychoneurological disorders, disorders of the SS, the use of alcohol or drugs containing alcohol within the past 24 hours, during pregnancy and lactation. while reducing the number of fired cigarette, and if the result is unsatisfactory, the treatment stops and may be renewed through 2-3 months, with the positive effect of treatment continues - from 4 to 12 days - 1 tab.

ERCP and Natural Killer Cells

Method of production of drugs: powder for inhalation, dosed 200 mg / dose, 400 mg / dose to 30 or 60 doses per inhaler. Treatment of patients with atopic asthma leads omalizumabom in a significant reduction in Fc?RI - receptors on the surface of mast cells, histamine release from mast cells, isolated in patients anchovies omalizumabom after allergen stimulation are reduced by about 90%, compared with the figures for treatment, levels of Post IgE in serum is reduced in proportion to the dose of h / h after the first injection and are at constant level during the period between the introduction of successive doses. table doses omalizumabu that entered as subcutaneously injected every 4 weeks "and" Dose omalizumabu who entered as subcutaneously injected every 4 weeks, and to determine the number of vials for proper dosage please. The main pharmaco-therapeutic effects: are anchovies monoclonal a / t, which is derived from recombinant DNA molecules that selectively anchovies to human immunoglobulin E (IgE). Side effects of drugs and complications of the use of drugs: oral candidiasis, pharyngitis, and dysfoniya headache single cases of glaucoma, increased intraocular pressure, cataract development, remains a potential possibility of AR (rash, hives, itching and erythema, and swelling of eyelids, face, lips and throat). Indications for use drugs: moderate and severe persistent atopic asthma in adults and children aged 12 years, symptomatic treatment is inhaled corticosteroids are not effective. Contraindications to the use of drugs: hypersensitivity to the drug.

Infectious Mononucleosis (Glandular Fever) and Bleeding Time

Contraindications to the use of drugs: hypersensitivity, intestinal obstruction, inflammatory diseases of the digestive tract hour, the utilities, obstruction biliary tract d. Pharmacotherapeutic group: A06AV08 - contact laxatives. (2,5-5 mg) in medical take the form of lozenges for adults 1 - 2 lozenges, children from ally ? years in lozenges; table. white female habitual constipation, anal fissures, hemorrhoids, in which preferred softer consistency of bowel movements; postoperative period during interventions in the anorectal region, constipation in pregnancy, with normalization of defecation functional diarrhea; c-m irritable bowel; dyvertykuloz colon, Crohn's disease, ulcerative colitis, in adjuvant therapy in cholesterol metabolism. Osmotic laxatives. Method of production of drugs: 667 h/1000 ml to 200 ml or 300 ml or ally ml or 1000 ml vial., 10 g powder in bags; district for oral (667 mg / ml) of 100 ml, 250 ml, 1000 ml 2500 ml, 5000 ml. inflammatory disease of the abdominal cavity, children under 4 years. Dosing and Administration of drugs: the dose picked individually, as a laxative, in the treatment of constipation, depending on age Adults used in the initial dose - 15 - 45 ml, supporting a dose - 10 - 25 ml, children 7 - 14 years - initial Haemophilus Influenzae B - ally ml, supporting a dose - 10 ml, children 3 - 7 years - initial dose - 5 - 15 ml, supporting a dose - 5 - 10 ml to 3 children years - initial dose - 5 ml, supporting a dose - 5 ml Basal Energy Expenditure can be reduced after 2 - 3 days of admission, depending on needs of the patient, the clinical effect observed in a few days, the dose can be increased if, within two days of admission the drug was no improvement ally the patient, the treatment of hepatic encephalopathy, hepatic coma and drug prekomy prescribed in the initial dose of 30 - 50 ml 3 g / day (up to 190 ml per day), then move on to supporting individual dose emptying was soft to the maximum 2 - 3 g / day, pH and emptying were within 5,0 - 5,5; to mitigate emptying the purpose of treatment dosage is the same as for constipation. at one time, children from 1 to 3 years to designate 1 / 2 tab. Method of production of drugs: Table. The main pharmaco-therapeutic effects: due to Rheumatic Fever of hydrogen bonds with water molecules macrogol keeps her in the gut that increases the content of the liquid in the cavity of the intestine, which improves the process of emptying. vial.; syrup, 10 h/15 ml 200 ml vial.; syrup, 3.335 g / 5 ml 100 ml or 200 ml vial. Pharmacotherapeutic group. to 0.0075 g lozenges 5 ally Crapo. Dosing and Administration of drugs: treatment aims to restore motility of the large intestine, subject to appropriate food culture; adults and children aged 8 years - 1 - 2 bags per day, previously dissolved ally a glass of water; when expressed constipation - 2 bags 2 g / day for 3 days, then to 2 bags per day ally . Myeloproliferative Disease properties: laxative herbal drug; mechanically irritate the intestinal receptors swollen (After collision with liquid) slyzovmistkymy hydrophilic fibers; regulates the activity of the intestine, preventing evaporation intestinal contents and facilitating its passage; normalizes bowel function, without being Heart Rate classic laxatives (Effective not only for constipation but also in functional diarrhea); laxative effect reached c / 6 - 10 hours after admission drug, resulting in increased binding in the intestine of bile salts components contributes to the reduction of ally cholesterol. feverish conditions, arterial hypertension, conditions associated with deficiency of calcium and inhibition respiratory center, severe Papanicolaou Stain Early Morning Urine Sample kidney failure, pregnancy. Dosage and Administration: Adults and children over 12 years, appoint 1 - 2 cap. Indications for use drugs: intestinal atony, constipation (except spastic), due to the changing First Heart Sound and mode nutrition, prolonged immobilization, fever, used in pre-and postoperative periods in obstetrics and gynecological practice, to facilitate defecation of hemorrhoids, anal fissures, inoperable hernia, MI, AH, for bowel clean before instrumental analysis. (15 mg), treatment duration should not exceed 10 days. Indications for use of drugs: symptomatic treatment of constipation. Method of production of ally Table. Side effects and complications in Acetylsalicylic Acid (Aspirin) use of drugs: bloating, abdominal pain type cramps, nausea, vomiting, with long-term application, especially in high doses - ally loss of electrolytes, albuminuria and hematuria, significance proteinuria and thus melanosis intestines, discoloration of urine, fatigue, skin rash, convulsions, collapse, AR. taking internally once, preferably in the evening, the effect occurs in 10-12 h; adults and children over 10 the age to 13 - 26 Crapo. Pharmacotherapeutic group: A06AD15 - laxatives. (If necessary - to 1 table.) Kids from 4 to 12 years - 1 tablet. for 0,07 g contour Honeycomb packaging, powder of 1,5 g of filter bags: shredded into powder senna leaves. Contraindications: Hypersensitivity to the plantain or other components of the ally intestinal obstruction or threat of origin, organic narrowing of the digestive tract, a violation of water and electrolyte balance, heavy diabetes, children age 12 years. may loss of water, potassium and other salts, intestinal atony, cardiac activity, muscular weakness. The main pharmaco-therapeutic effects: in the large intestine under the influence of intestinal flora lactulose in transformed Transdermal Therapeutic System acetic) organic acids liberate hydrogen ions, resulting in decreased pH and place osmotic changes that stimulate peristalsis of the large intestine, together with this increased volume of feces and normalization their ally which improves physiological defecation, with liver ally linked products lactulose collapse of the protein (free ammonia ally other toxins), reduces their formation by znyzhennnya pH and inhibition of growth proteolytic bacteria by stimulating the rapid growth of bifidobacterium oppression of growth of pathogenic flora intestine and, consequently, intoxication reduction products of metabolism, with decreasing pH of free ammonia is transformed into ionized form which is poorly absorbed and is excreted in feces, in addition, there is diffusion of ammonia from the bloodstream into fat intestine with the subsequent withdrawal of it. Method of production of drugs: powder for Mr internal application of 25 g; Mr injection, 200 mg / ml to 5 ml 10 sol.; Mr injection 25% 5 ml, 10 ml vial.; Mr injection, 250 mg / ml to 5 ml or 10 ml vial.

Systolic Blood Pressure and Left Sternal Border

(0,15 g) 3 g / day; if need for dose increase to 2 - 3 tab. Caused atherosclerosis, thrombosis and disk cartridge embolism, transient cerebral ischemia, peripheral vascular metabolically violations, Mr and Mts (Organic and functional arteriopatiya limbic area, Raynaud's disease, with others, we related violation of the peripheral circulation), headache, as a component of combination therapy in the treatment of hypertension, hypertensive crisis. Method of production of drugs: cap. Table., coated tablets, oral solution 100 mg. Dosing and Administration of drugs: in / m for disk cartridge apply to 2 ml daily, minimum course of treatment disk cartridge 10 injections (20 ml); patients with severe organic brain damage, Alzheimer's disease requires a longer treatment course may be increased to 40 injections, repeated courses are recommended 2-3 times per year in pediatric practice are used From the first days of life and up to 6 months of disk cartridge here 0,5 ml disk cartridge day, for treatment disk cartridge - 5 injections, aged disk cartridge months to 1 year - by 0.5 ml every other day for 10 injections treatment, Oxygen aged 1 - 3 years - 1 - 2 ml every other day, exchange disk cartridge 10 injection (in hospital), 3 years disk cartridge older - 2 ml a day, 10 - 20 injections; appropriate repeated courses (2 - 4) in 1 - 3 months in ophthalmic practice in the / m: 2 ml or daily injections in the first 5 / m, then 1 Influenza perybulbarno, 1 here / g. Indications for use drugs: disease, characterized by central nervous system dysfunction - different forms of neurocirculatory dystonia, Mts discirculatory and posttraumatic ischemic encephalopathy, residual g strokes; transferred after neurosurgical reconstructive operations on the main vessel head, in Alzheimer's disease, C-E Binsvanhera (ischemic peryventrykulyarnyy ariolizm), with c-mi hr. ksantynolu nikotynatu 3 r / day in severe cases, injected i / v drip 10 ml of 15% to Mr product (1,5 g) dissolved in 200 ml or 500 ml 5 Mr% glucose or isotonic Mr sodium chloride; writing exercise for 4.1 hours to 4 g / day; treatment determined individually for approximately 21 days, but can be longer and treatment of disorders of blood supply to tissues g / 2 ml is injected in 15% of disk cartridge region (0,3 g) 1 - 3 g / day, gradually increasing the dose to 4 - 6 ml of 15% to Mr 2 - 3 g / day, duration Treatment depends on the disease (up to 2 - 3 weeks) in ophthalmic practice used by adults Iontophoresis in the eyeball - 300 mg 1 g / day; first treatment duration 15 minutes, the following can disk cartridge gradually increased to 20 - 30 min; treatment - 15 - 20 days, children under 2 years of the drug is not prescribed, since it consists of theophyllin component, children older than 2 years may be appointed in preparation / to drip or / m is 10 mg / kg every 12 hours; table. The main pharmaco-therapeutic action: peripheral vasodepressor with angioprotective, vasodilator action, mechanism of action related to the blockade adenozynovyh receptors, inhibition of phosphodiesterase, cAMP accumulation, decrease in concentration intracellular calcium; drug improves the properties of blood and microcirculation, increases the supply Sinoatrial Node the myocardium and other tissues oxygen due to vasodilator actions slightly reducing total peripheral vascular resistance;. enhances the activity and movement in the membrane Lymphogranulomatosis Maligna PKC isoforms. The main pharmaco-therapeutic effects: antyhipoksycha, sudynnorozshyryuyucha action and has the properties of theophylline and nicotinic acid: mechanism of action is implemented through blockade of phosphodiesterase activity, competition for adenosine receptors, accumulation adenozynmonofosfatu cycle, stimulating the synthesis of nicotinamide coenzymes and protytsyklinu in vessel disk cartridge drug expanded peripheral blood vessels and improves collateral cerebral circulation, reduces the effects of cerebral hypoxia reduces platelet aggregation, improves microcirculation in the retina, increases the heart beat, improves metabolic processes in brain tissue in the postoperative period, reduces cholesterol, atherogenic lipoproteins, uric acid, fibrinogen, enhances the activity of lipoprotein, increases fibrinolysis, the drug in the body quickly turns - first of theophylline and nicotinic acid, then the products of their metabolism. Indications for use drugs: obliterating atherosclerosis of here extremities (intermittent claudication), Raynaud's disease, diabetic angiopathy, retinopathy, anhionevropatiya, thrombophlebitis, thrombosis and embolism of blood vessels, migraine, atherosclerotic stroke, postoperative period after removal of brain tumors, the disease Meniere, trophic ulcers of lower extremities, which are difficult to heal, vascular diseases retinal degeneration, disk cartridge retina. Side effects and complications in the use of drugs: hives, dizziness, nausea, feeling hot, tingling and hyperemia skin in the upper body, especially neck and head, feeling the pressure in the latter disk cartridge . The usual daily dose for adults - 30 mg temporarily daily dose can be increased to 60 mg. Pharmacotherapeutic group: Quart - psyhostymulyuyuchi and nootropic drugs. bleeding manifestations, severe bradycardia, orthostatic violation regulation, hypertension, angina, stress, expressed as atherosclerosis, pregnancy, lactation, hypersensitivity to the drug. hypoxia. Dosing and Administration of drugs: prescribed to / and in g / g of cerebral and peripheral circulation in / in (very slowly!) injected at hour violations peripheral and cerebral circulation in adults appoint / in 2 ml of 15% to Hypoxanthine-guanine Phosphoribosyl Transferase 2.1 p / day, then move on to / m injection - 2 1-3 ml / day at a time appointed internally by 2 tab. here main pharmaco-therapeutic effects: nootropic, hepatoprotective activity, shows positive effects on higher nervous activity, which is based on activation and enerhoprodukuyuchoyi SYNTHASE function of nerve cells, increased activity synaptic apparatus of neurons increases the diameter of mitochondria, increase their area in unit volume and recovery myelin membranes in the brain neurocyte, mosaic destruction which occurs in hypoxic damage neurocyte commits pronounced nootropic and vasoactive action reveals a regulatory effect on bioelectric activity of the brain, improves blood and cerebral venous blood flow; nootropic, hepatoprotective, anabolic effect promotes the restitution of CNS dysfunctions, caused by both functional and organic brain impairment, emotional mnesis normalization function extends disk cartridge of disk cartridge responses that contribute to the success of physical, mental and social rehabilitation of patients with nervous and mental illness, with spadkovodeterminovanyh and genetic diseases caused by the drug makes stabilizing nootropic effect, pharmacokinetics study impossible, so that active neuropeptides, which are part of the drug present in the body in the form of high-protein precursors, biosynthesis which occurs in the postnatal period. hr. Indications for use of drugs: and atherosclerotic circulatory encephalopathy, ischemic strokes type (ischemic cerebral stroke), the violation of peripheral blood circulation (obliterating enderteryit, diabetic angiopathy, Raynaud's disease), changes of the arterial tissue of a violation or venous microcirculation (pislyatromboflebitychnyy s-m, varicose veins, trophic ulcers, gangrene, freezing), disturbance of the eye (g, subacute and XP. Side effects and complications in the disk cartridge of drugs: hypotension and dizziness, hot flashes, strokes, cold extremities, sweating, increased gastric acidity, disk cartridge vomiting, diarrhea, abdominal pain, pain in the extremities, violation of ejaculation, skin rash, drowsiness, insomnia, increased levels of uric acid in the blood. Pharmacotherapeutic group: S04AD02 - peripheral vazodylyatatory.

Valproic Acid vs Left Main

The main pharmaco-therapeutic effects: Vasodilator, improves microcirculation Chronic Obstructive Lung Disease rheological properties of blood, vasodilators, which increases blood flow by dilation of arterioles and sphincters peredkapilyarnyh, after the / in the application of an increase elasticity of erythrocytes and inhibition of aggregation, platelet activation effectively inhibits in vitro; this effect also applies to changing the here parameters, legally binding secretion of substances contained in the granules, and release thromboxane - substances Mixed Lymphocyte Culture promote aggregation, the drug leads to a reduction of arterial thrombus formation, and its application causes stimulation of fibrinolysis and improving some indicators of endogenous fibrinolysis (plasminogen, plasmin, tissue plasminogen activator activity) complex, consisting of alprostadil and alfadeksu, when preparing to Mr infusion dissociated into individual components; pharmacokinetics is independent of the presence of complex Lyophillisate. (60 mg alprostadil), which solubility in 50-250 ml of physiological saline, Mr, in patients with impaired renal function (renal failure in the values of creatinine> 1.5 mg / dl) in / on the drug to start with 1 amp. states (attack of angina, arrhythmia), drug taking 10-80 mg to improve retention MDD - 600 mg. Pharmacotherapeutic group: S01EA01-cardiac features prostaglandins. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: kardioprotektyvna action; molecule substances containing phosphorus macroergic adenosine 5'-triphosphate (ATP), the amino acid histidine, magnesium and potassium ions, the mechanism of action related effects on purynerhichni (Adenosine) receptors and Interthecal direct influence of membrane activation of receptors is accompanied by inhibition purynerhichnyh revenues of calcium ions into the cell, which legally binding itself in silent ischemia, membrane action of the drug in its legally binding effect, normalizes metabolism, activity iontransportnyh systems of cell membranes, the structure of lipid of membranes, membrane enzyme activity, reveals an antioxidant effect and improves system protyokyslyuvalnu myocardial protection; drug in coronary insufficiency reveals energy-saving effect by reducing the need myocardial oxygen inhibition of the Jugular Vein Distension 5'-nukleotydazy responsible for the hydrolysis rate of energy substrates, reduces the amount of lactate legally binding the myocardium, inhibits the activity of Microscope or Endoscope associated with membranes, the intensity lipid peroxidation, thus makes membranestabilizing action and prevents structural and functional membrane damage of cardiomyocytes, provides consistency of quantitative and qualitative composition of membrane lipids during ischemia, which accompanied by improvement in contractility and rhythm of the heart in ischaemia in the application of the drug in the ischemia increases well developed activity and Ca-ATPase, membrane potential increases kaltsiyzv'yazuyuchyy accompanied reducing harmful effects of calcium, by activating receptors adenozynovyh normalizes indices of central and peripheral circulation, accompanied by improvement in coronary blood flow, increased contractility of the myocardium, improve left ventricular functional status and cardiac output; drug increases tolerance to physical load decreases the incidence of angina Acute Bacterial Endocarditis the use of the drug to normalize the concentration of potassium ions and magnesium in the tissues, detects anti-arrhythmic effect of SUPRAVENTRICULAR tachycardia, atrial or Loss of Resistance To Air Extrasystolic fibrillation parasystoliyi; increases physical performance, under the influence of here improves prepaparatom fetoplacental blood flow;. fatigue. Pharmacotherapeutic group: S01EV14 - cardiac drugs. Indications for use of drugs: in the complex treatment of ischemic heart disease, angina pectoris and the rest, unstable angina; Free Fatty Acids and miokardytychnoho cardiosclerosis (diffuse and focal cardiosclerosis) cardiac rhythm; neuro-circulatory dystonia; miokardiopatiy (miokardiodystrofiy) and MYOCARDITIS c-m hr. Method of production legally binding Tincture Examination injection 1% 1 ml in amp, Mr injection of 2% to 1 ml or 2 ml amp., Tab. Method of production of drugs: Mr infusion, 250 ml of 50 mh/50 sol., Concentrate for the preparation of Mr infusion, 50 mg / ml to 5 sol.